| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Heme Oxygenase-1 | 15 | 2020 | 364 | 4.090 |
Why?
|
| Heme | 8 | 2023 | 313 | 3.890 |
Why?
|
| Carbon Monoxide | 17 | 2020 | 540 | 3.620 |
Why?
|
| Oxidoreductases Acting on CH-CH Group Donors | 3 | 2019 | 174 | 1.250 |
Why?
|
| Macrophages | 12 | 2020 | 5745 | 1.210 |
Why?
|
| Hemopexin | 2 | 2023 | 32 | 0.950 |
Why?
|
| Cyclin A | 3 | 2008 | 60 | 0.880 |
Why?
|
| Membrane Proteins | 7 | 2020 | 7850 | 0.860 |
Why?
|
| Biliverdine | 5 | 2020 | 28 | 0.850 |
Why?
|
| Cell Proliferation | 15 | 2020 | 10446 | 0.820 |
Why?
|
| G-Quadruplexes | 2 | 2021 | 190 | 0.770 |
Why?
|
| Receptor, Anaphylatoxin C5a | 2 | 2019 | 87 | 0.760 |
Why?
|
| Prostatic Neoplasms | 9 | 2022 | 11345 | 0.750 |
Why?
|
| Hemolysis | 1 | 2023 | 423 | 0.750 |
Why?
|
| Mycobacterium bovis | 1 | 2021 | 147 | 0.730 |
Why?
|
| Cell Fractionation | 1 | 2021 | 251 | 0.730 |
Why?
|
| Colorimetry | 1 | 2021 | 153 | 0.720 |
Why?
|
| Chalcones | 2 | 2016 | 29 | 0.670 |
Why?
|
| Complement C5a | 1 | 2019 | 100 | 0.650 |
Why?
|
| Radiation Injuries, Experimental | 1 | 2019 | 88 | 0.630 |
Why?
|
| Inflammation | 6 | 2023 | 10756 | 0.580 |
Why?
|
| Immunity | 2 | 2021 | 998 | 0.570 |
Why?
|
| L-Lactate Dehydrogenase | 1 | 2017 | 412 | 0.520 |
Why?
|
| Chemotaxis | 1 | 2019 | 598 | 0.520 |
Why?
|
| Stathmin | 1 | 2016 | 70 | 0.520 |
Why?
|
| Escherichia coli Infections | 1 | 2020 | 523 | 0.520 |
Why?
|
| Histones | 3 | 2015 | 2583 | 0.510 |
Why?
|
| Myeloid Cells | 2 | 2017 | 820 | 0.490 |
Why?
|
| Chemokines | 1 | 2019 | 962 | 0.480 |
Why?
|
| Nuclear Receptor Subfamily 1, Group D, Member 1 | 1 | 2014 | 32 | 0.460 |
Why?
|
| DNA Damage | 2 | 2021 | 2442 | 0.460 |
Why?
|
| Nitric Oxide Synthase Type III | 4 | 2011 | 704 | 0.460 |
Why?
|
| Proto-Oncogene Proteins c-akt | 4 | 2014 | 2448 | 0.450 |
Why?
|
| Myeloid Progenitor Cells | 1 | 2014 | 114 | 0.440 |
Why?
|
| Endometriosis | 1 | 2021 | 874 | 0.420 |
Why?
|
| Nitric Oxide | 4 | 2011 | 2141 | 0.410 |
Why?
|
| DNA | 3 | 2020 | 7233 | 0.410 |
Why?
|
| Blood Coagulation Disorders | 1 | 2015 | 349 | 0.410 |
Why?
|
| Nucleosomes | 1 | 2015 | 484 | 0.400 |
Why?
|
| Prostate | 1 | 2020 | 1793 | 0.380 |
Why?
|
| Lipid Metabolism | 1 | 2020 | 1902 | 0.380 |
Why?
|
| Cell Line, Tumor | 13 | 2021 | 16939 | 0.380 |
Why?
|
| Bilirubin | 3 | 2020 | 438 | 0.370 |
Why?
|
| Vascular Endothelial Growth Factor Receptor-2 | 2 | 2014 | 544 | 0.360 |
Why?
|
| Vascular System Injuries | 1 | 2014 | 247 | 0.350 |
Why?
|
| Laminin | 2 | 2014 | 405 | 0.340 |
Why?
|
| Tumor Microenvironment | 4 | 2021 | 3844 | 0.340 |
Why?
|
| Vascular Endothelial Growth Factor A | 5 | 2008 | 3484 | 0.340 |
Why?
|
| Blood Coagulation | 1 | 2015 | 1157 | 0.330 |
Why?
|
| Inflammasomes | 1 | 2014 | 530 | 0.330 |
Why?
|
| Carotid Artery Injuries | 1 | 2010 | 96 | 0.330 |
Why?
|
| Animals | 33 | 2023 | 167963 | 0.330 |
Why?
|
| Phosphatidylinositol 3-Kinases | 2 | 2009 | 2864 | 0.320 |
Why?
|
| Signal Transduction | 12 | 2021 | 23376 | 0.320 |
Why?
|
| Molecular Targeted Therapy | 2 | 2021 | 2803 | 0.320 |
Why?
|
| Mice | 22 | 2023 | 81208 | 0.320 |
Why?
|
| Drugs, Chinese Herbal | 1 | 2010 | 151 | 0.310 |
Why?
|
| Tuberculosis | 1 | 2021 | 2001 | 0.310 |
Why?
|
| Cystatin C | 1 | 2009 | 270 | 0.310 |
Why?
|
| Cell Nucleus | 2 | 2020 | 2907 | 0.300 |
Why?
|
| Toll-Like Receptor 4 | 1 | 2011 | 580 | 0.300 |
Why?
|
| Apoptosis | 9 | 2021 | 9501 | 0.300 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p27 | 1 | 2008 | 319 | 0.300 |
Why?
|
| Indoles | 1 | 2016 | 1829 | 0.290 |
Why?
|
| Neoplasm Metastasis | 3 | 2020 | 4902 | 0.290 |
Why?
|
| Cell Cycle | 3 | 2020 | 2934 | 0.290 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2011 | 1173 | 0.280 |
Why?
|
| Collagen Type I | 1 | 2010 | 616 | 0.280 |
Why?
|
| Mice, Knockout | 7 | 2023 | 14372 | 0.270 |
Why?
|
| Mice, Inbred C57BL | 9 | 2020 | 22023 | 0.270 |
Why?
|
| Mice, Transgenic | 5 | 2019 | 9530 | 0.270 |
Why?
|
| Receptors, Androgen | 2 | 2009 | 1077 | 0.270 |
Why?
|
| Bone Marrow Transplantation | 2 | 2014 | 2693 | 0.260 |
Why?
|
| Gene Expression Regulation, Neoplastic | 6 | 2020 | 8515 | 0.260 |
Why?
|
| Immunity, Innate | 2 | 2015 | 3047 | 0.260 |
Why?
|
| Endothelial Cells | 4 | 2014 | 3539 | 0.260 |
Why?
|
| Neoplasms | 4 | 2021 | 22072 | 0.240 |
Why?
|
| Androgens | 2 | 2010 | 1291 | 0.240 |
Why?
|
| Gene Expression Regulation | 3 | 2021 | 11903 | 0.240 |
Why?
|
| Osteoblasts | 1 | 2010 | 1142 | 0.240 |
Why?
|
| Camptothecin | 1 | 2008 | 590 | 0.230 |
Why?
|
| Antineoplastic Agents, Phytogenic | 1 | 2008 | 626 | 0.230 |
Why?
|
| Lung Neoplasms | 3 | 2017 | 13262 | 0.220 |
Why?
|
| Cyclin A1 | 3 | 2008 | 11 | 0.220 |
Why?
|
| MAP Kinase Signaling System | 1 | 2009 | 1484 | 0.210 |
Why?
|
| Energy Metabolism | 1 | 2013 | 2869 | 0.200 |
Why?
|
| DNA Repair | 1 | 2011 | 2039 | 0.200 |
Why?
|
| Aorta | 1 | 2010 | 2039 | 0.200 |
Why?
|
| Doxorubicin | 2 | 2023 | 2209 | 0.190 |
Why?
|
| Interleukin-1beta | 2 | 2020 | 998 | 0.190 |
Why?
|
| Cell Membrane | 2 | 2021 | 3682 | 0.190 |
Why?
|
| Cells, Immobilized | 1 | 2021 | 35 | 0.190 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2011 | 2802 | 0.190 |
Why?
|
| Administration, Inhalation | 2 | 2014 | 1156 | 0.190 |
Why?
|
| Endothelium, Vascular | 2 | 2010 | 4433 | 0.180 |
Why?
|
| Coenzyme A Ligases | 1 | 2020 | 45 | 0.170 |
Why?
|
| Cell Differentiation | 2 | 2015 | 11481 | 0.170 |
Why?
|
| Homeostasis | 2 | 2008 | 3306 | 0.170 |
Why?
|
| Cells, Cultured | 8 | 2016 | 18957 | 0.170 |
Why?
|
| Calcium | 2 | 2010 | 5725 | 0.170 |
Why?
|
| Cell Cycle Proteins | 1 | 2011 | 3446 | 0.170 |
Why?
|
| Urokinase-Type Plasminogen Activator | 1 | 2020 | 326 | 0.170 |
Why?
|
| Neoplasm Invasiveness | 3 | 2016 | 3618 | 0.170 |
Why?
|
| Humans | 39 | 2023 | 760621 | 0.160 |
Why?
|
| BCG Vaccine | 1 | 2021 | 371 | 0.160 |
Why?
|
| Interleukin-6 | 1 | 2008 | 3215 | 0.150 |
Why?
|
| Phosphorylation | 5 | 2016 | 8313 | 0.150 |
Why?
|
| Epithelial-Mesenchymal Transition | 1 | 2022 | 730 | 0.150 |
Why?
|
| Metribolone | 2 | 2008 | 13 | 0.150 |
Why?
|
| TOR Serine-Threonine Kinases | 2 | 2019 | 2058 | 0.150 |
Why?
|
| Hematopoietic Stem Cells | 1 | 2010 | 3387 | 0.140 |
Why?
|
| Matrix Metalloproteinase 2 | 2 | 2009 | 461 | 0.140 |
Why?
|
| Transfection | 2 | 2019 | 5781 | 0.130 |
Why?
|
| Cell Movement | 4 | 2014 | 5206 | 0.130 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p16 | 1 | 2019 | 698 | 0.130 |
Why?
|
| Colon | 1 | 2023 | 1788 | 0.120 |
Why?
|
| Escherichia coli | 2 | 2020 | 4219 | 0.120 |
Why?
|
| Up-Regulation | 3 | 2008 | 4122 | 0.120 |
Why?
|
| Proto-Oncogene Proteins c-myc | 1 | 2020 | 995 | 0.120 |
Why?
|
| Immunoblotting | 2 | 2008 | 1649 | 0.120 |
Why?
|
| Disease Progression | 3 | 2020 | 13502 | 0.120 |
Why?
|
| Mitogen-Activated Protein Kinase 3 | 1 | 2016 | 474 | 0.120 |
Why?
|
| Drug Synergism | 2 | 2021 | 1754 | 0.120 |
Why?
|
| Mitogen-Activated Protein Kinase 1 | 1 | 2016 | 478 | 0.120 |
Why?
|
| Gene Knockdown Techniques | 1 | 2019 | 1617 | 0.120 |
Why?
|
| Retinoblastoma Protein | 2 | 2010 | 670 | 0.120 |
Why?
|
| Hemeproteins | 1 | 2014 | 61 | 0.110 |
Why?
|
| Receptor, Macrophage Colony-Stimulating Factor | 1 | 2014 | 94 | 0.110 |
Why?
|
| DNA-Binding Proteins | 1 | 2011 | 9585 | 0.110 |
Why?
|
| U937 Cells | 1 | 2014 | 262 | 0.110 |
Why?
|
| Interleukin-1alpha | 1 | 2014 | 86 | 0.110 |
Why?
|
| Macrophage Colony-Stimulating Factor | 1 | 2014 | 186 | 0.110 |
Why?
|
| Cell Culture Techniques | 1 | 2021 | 1664 | 0.110 |
Why?
|
| Cell Respiration | 1 | 2014 | 202 | 0.110 |
Why?
|
| Gases | 1 | 2014 | 203 | 0.110 |
Why?
|
| Models, Immunological | 1 | 2015 | 513 | 0.110 |
Why?
|
| Cytotoxicity, Immunologic | 1 | 2017 | 1351 | 0.110 |
Why?
|
| Phosphatidylinositol 3-Kinase | 1 | 2014 | 126 | 0.110 |
Why?
|
| Co-Repressor Proteins | 1 | 2014 | 191 | 0.110 |
Why?
|
| Biosynthetic Pathways | 1 | 2014 | 135 | 0.110 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 1 | 2016 | 687 | 0.110 |
Why?
|
| Endotoxins | 2 | 2014 | 521 | 0.110 |
Why?
|
| Cell Death | 2 | 2016 | 1672 | 0.110 |
Why?
|
| Promoter Regions, Genetic | 3 | 2020 | 5785 | 0.100 |
Why?
|
| Leukemia, Myeloid, Acute | 1 | 2008 | 3602 | 0.100 |
Why?
|
| Kruppel-Like Transcription Factors | 1 | 2015 | 503 | 0.100 |
Why?
|
| Hep G2 Cells | 1 | 2013 | 389 | 0.100 |
Why?
|
| Isoenzymes | 1 | 2017 | 1690 | 0.100 |
Why?
|
| Reperfusion Injury | 4 | 2012 | 1023 | 0.100 |
Why?
|
| Male | 14 | 2022 | 359744 | 0.100 |
Why?
|
| Glycogen Synthase Kinase 3 | 1 | 2014 | 410 | 0.100 |
Why?
|
| NIH 3T3 Cells | 1 | 2013 | 670 | 0.100 |
Why?
|
| Phenotype | 2 | 2020 | 16546 | 0.100 |
Why?
|
| Reactive Oxygen Species | 3 | 2016 | 2138 | 0.100 |
Why?
|
| Chemokine CCL2 | 1 | 2014 | 605 | 0.100 |
Why?
|
| Neovascularization, Pathologic | 2 | 2014 | 2640 | 0.090 |
Why?
|
| Gene Deletion | 1 | 2019 | 2668 | 0.090 |
Why?
|
| Transplantation Chimera | 1 | 2014 | 595 | 0.090 |
Why?
|
| Macrophage Activation | 1 | 2014 | 554 | 0.090 |
Why?
|
| Acetylation | 1 | 2014 | 1062 | 0.090 |
Why?
|
| Cadherins | 1 | 2015 | 898 | 0.090 |
Why?
|
| Delayed Graft Function | 1 | 2010 | 49 | 0.090 |
Why?
|
| Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 2014 | 886 | 0.090 |
Why?
|
| Small Molecule Libraries | 1 | 2016 | 734 | 0.090 |
Why?
|
| Potassium | 1 | 2014 | 1313 | 0.090 |
Why?
|
| Microtubules | 1 | 2016 | 1072 | 0.090 |
Why?
|
| Active Transport, Cell Nucleus | 1 | 2011 | 435 | 0.090 |
Why?
|
| Protoporphyrins | 2 | 2012 | 165 | 0.090 |
Why?
|
| Transcription Factor AP-1 | 1 | 2011 | 321 | 0.090 |
Why?
|
| Cytoprotection | 2 | 2007 | 200 | 0.090 |
Why?
|
| Genes, Transgenic, Suicide | 1 | 2009 | 34 | 0.080 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 2 | 2008 | 3804 | 0.080 |
Why?
|
| Cytosine Deaminase | 1 | 2009 | 65 | 0.080 |
Why?
|
| Sepsis | 2 | 2014 | 2592 | 0.080 |
Why?
|
| Chromatin Assembly and Disassembly | 1 | 2014 | 633 | 0.080 |
Why?
|
| Histone Deacetylases | 1 | 2014 | 718 | 0.080 |
Why?
|
| Vaccination | 1 | 2021 | 3361 | 0.080 |
Why?
|
| Interleukin-10 | 3 | 2009 | 1175 | 0.080 |
Why?
|
| Phagocytosis | 1 | 2014 | 1535 | 0.080 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 1 | 2016 | 1728 | 0.080 |
Why?
|
| rhoA GTP-Binding Protein | 1 | 2010 | 235 | 0.080 |
Why?
|
| Protein Kinase C-delta | 1 | 2009 | 114 | 0.080 |
Why?
|
| Gene Expression | 1 | 2021 | 7588 | 0.080 |
Why?
|
| Lipopolysaccharides | 2 | 2014 | 2209 | 0.080 |
Why?
|
| Subcellular Fractions | 1 | 2009 | 532 | 0.080 |
Why?
|
| Adenosine Triphosphate | 1 | 2014 | 1993 | 0.080 |
Why?
|
| MAP Kinase Kinase 2 | 1 | 2008 | 92 | 0.080 |
Why?
|
| Transcriptional Activation | 1 | 2014 | 1755 | 0.070 |
Why?
|
| Multiprotein Complexes | 1 | 2014 | 1120 | 0.070 |
Why?
|
| HeLa Cells | 1 | 2013 | 3105 | 0.070 |
Why?
|
| Leukemia | 1 | 2015 | 1520 | 0.070 |
Why?
|
| Heme Oxygenase (Decyclizing) | 1 | 2007 | 167 | 0.070 |
Why?
|
| Mice, Nude | 1 | 2013 | 3607 | 0.070 |
Why?
|
| Rats | 3 | 2014 | 23711 | 0.070 |
Why?
|
| Hypoxia-Inducible Factor 1, alpha Subunit | 2 | 2009 | 621 | 0.070 |
Why?
|
| DNA Breaks, Double-Stranded | 1 | 2011 | 607 | 0.070 |
Why?
|
| Receptor, Adenosine A2A | 1 | 2007 | 128 | 0.070 |
Why?
|
| Ischemic Preconditioning | 1 | 2007 | 89 | 0.070 |
Why?
|
| MAP Kinase Kinase 1 | 1 | 2008 | 331 | 0.070 |
Why?
|
| Drug Resistance, Neoplasm | 2 | 2013 | 5253 | 0.070 |
Why?
|
| Host-Pathogen Interactions | 1 | 2014 | 1447 | 0.060 |
Why?
|
| Immunotherapy | 1 | 2021 | 4642 | 0.060 |
Why?
|
| Chromatin Immunoprecipitation | 1 | 2008 | 858 | 0.060 |
Why?
|
| Iron | 1 | 2014 | 1786 | 0.060 |
Why?
|
| Cobalt | 1 | 2005 | 155 | 0.060 |
Why?
|
| Matrix Metalloproteinase 9 | 1 | 2008 | 632 | 0.060 |
Why?
|
| Cell Lineage | 1 | 2014 | 2533 | 0.060 |
Why?
|
| Mitochondria | 3 | 2014 | 3600 | 0.060 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2009 | 4573 | 0.060 |
Why?
|
| HEK293 Cells | 1 | 2014 | 4264 | 0.060 |
Why?
|
| Autophagy | 1 | 2012 | 1337 | 0.060 |
Why?
|
| Biopsy | 1 | 2016 | 6771 | 0.060 |
Why?
|
| Down-Regulation | 2 | 2008 | 2913 | 0.060 |
Why?
|
| Pancreatic Neoplasms | 1 | 2021 | 5351 | 0.060 |
Why?
|
| Models, Animal | 1 | 2010 | 2117 | 0.050 |
Why?
|
| Immunohistochemistry | 2 | 2008 | 11071 | 0.050 |
Why?
|
| Photochemotherapy | 1 | 2009 | 820 | 0.050 |
Why?
|
| Plasmids | 1 | 2008 | 2275 | 0.050 |
Why?
|
| Wound Healing | 1 | 2014 | 2788 | 0.050 |
Why?
|
| Interleukin-8 | 1 | 2005 | 698 | 0.050 |
Why?
|
| PTEN Phosphohydrolase | 1 | 2008 | 1115 | 0.050 |
Why?
|
| Antineoplastic Agents | 2 | 2016 | 13630 | 0.050 |
Why?
|
| Adenosine | 1 | 2007 | 834 | 0.050 |
Why?
|
| Enzyme Activation | 1 | 2008 | 3602 | 0.050 |
Why?
|
| Equilibrative Nucleoside Transporter 1 | 1 | 2021 | 17 | 0.050 |
Why?
|
| Rats, Sprague-Dawley | 2 | 2010 | 8158 | 0.050 |
Why?
|
| Carrier Proteins | 1 | 2014 | 4938 | 0.050 |
Why?
|
| DNA Primers | 1 | 2005 | 2819 | 0.050 |
Why?
|
| Cell Survival | 2 | 2008 | 5797 | 0.050 |
Why?
|
| Osteoporosis | 1 | 2010 | 1600 | 0.040 |
Why?
|
| RNA, Small Interfering | 1 | 2009 | 3442 | 0.040 |
Why?
|
| Time Factors | 2 | 2014 | 40165 | 0.040 |
Why?
|
| Cell Line | 2 | 2014 | 15620 | 0.040 |
Why?
|
| Treatment Outcome | 3 | 2020 | 65017 | 0.040 |
Why?
|
| Muscle, Smooth, Vascular | 1 | 2006 | 1485 | 0.040 |
Why?
|
| Mitogen-Activated Protein Kinase Kinases | 1 | 2022 | 642 | 0.040 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2008 | 3775 | 0.040 |
Why?
|
| Transplantation, Heterologous | 1 | 2008 | 2379 | 0.040 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2009 | 1796 | 0.040 |
Why?
|
| Disease-Free Survival | 1 | 2009 | 6828 | 0.040 |
Why?
|
| Amino Acid Motifs | 1 | 2021 | 929 | 0.040 |
Why?
|
| RNA, Messenger | 3 | 2008 | 12766 | 0.040 |
Why?
|
| Neovascularization, Physiologic | 1 | 2005 | 1336 | 0.040 |
Why?
|
| Bone Marrow | 1 | 2008 | 2912 | 0.040 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 1 | 2016 | 5251 | 0.040 |
Why?
|
| Organ Transplantation | 1 | 2007 | 1150 | 0.040 |
Why?
|
| Endocytosis | 1 | 2021 | 959 | 0.040 |
Why?
|
| Deoxycytidine | 1 | 2021 | 873 | 0.030 |
Why?
|
| Disease Models, Animal | 2 | 2014 | 18137 | 0.030 |
Why?
|
| Microfilament Proteins | 1 | 2021 | 1135 | 0.030 |
Why?
|
| Lysosomes | 1 | 2021 | 920 | 0.030 |
Why?
|
| Liver | 1 | 2011 | 7509 | 0.030 |
Why?
|
| Models, Biological | 2 | 2009 | 9467 | 0.030 |
Why?
|
| Oncogenes | 1 | 2021 | 1220 | 0.030 |
Why?
|
| Kidney Neoplasms | 1 | 2012 | 4312 | 0.030 |
Why?
|
| Kidney Transplantation | 1 | 2010 | 4215 | 0.030 |
Why?
|
| Hypertension, Pulmonary | 1 | 2006 | 1570 | 0.030 |
Why?
|
| Diabetes Mellitus | 1 | 2014 | 5889 | 0.030 |
Why?
|
| Organoids | 1 | 2021 | 729 | 0.030 |
Why?
|
| Sumoylation | 1 | 2015 | 83 | 0.030 |
Why?
|
| Base Sequence | 1 | 2005 | 12446 | 0.030 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2021 | 3584 | 0.030 |
Why?
|
| Antioxidants | 2 | 2014 | 1667 | 0.030 |
Why?
|
| Immunoprecipitation | 1 | 2014 | 877 | 0.030 |
Why?
|
| Benzenesulfonates | 1 | 2012 | 165 | 0.020 |
Why?
|
| Proteoglycans | 1 | 2014 | 801 | 0.020 |
Why?
|
| Chromatin | 1 | 2022 | 2938 | 0.020 |
Why?
|
| Kidney Tubular Necrosis, Acute | 1 | 2010 | 65 | 0.020 |
Why?
|
| Organometallic Compounds | 1 | 2014 | 662 | 0.020 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2021 | 2895 | 0.020 |
Why?
|
| Tyrosine | 1 | 2014 | 1438 | 0.020 |
Why?
|
| Niacinamide | 1 | 2012 | 414 | 0.020 |
Why?
|
| Carcinoma, Pancreatic Ductal | 1 | 2021 | 1724 | 0.020 |
Why?
|
| Flucytosine | 1 | 2009 | 33 | 0.020 |
Why?
|
| Antimetabolites | 1 | 2009 | 128 | 0.020 |
Why?
|
| Phenylurea Compounds | 1 | 2012 | 529 | 0.020 |
Why?
|
| Receptors, Purinergic | 1 | 2009 | 66 | 0.020 |
Why?
|
| Drug Combinations | 1 | 2014 | 2025 | 0.020 |
Why?
|
| Survival Analysis | 1 | 2021 | 10182 | 0.020 |
Why?
|
| Lung | 3 | 2016 | 9994 | 0.020 |
Why?
|
| Adenosine-5'-(N-ethylcarboxamide) | 1 | 2007 | 15 | 0.020 |
Why?
|
| Prodrugs | 1 | 2009 | 259 | 0.020 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2015 | 1974 | 0.020 |
Why?
|
| Microtubule-Associated Proteins | 1 | 2012 | 1077 | 0.020 |
Why?
|
| Apoptosis Regulatory Proteins | 1 | 2012 | 1135 | 0.020 |
Why?
|
| Tacrolimus | 1 | 2010 | 733 | 0.020 |
Why?
|
| Nucleotides | 1 | 2009 | 450 | 0.020 |
Why?
|
| Collagen | 1 | 2014 | 2636 | 0.020 |
Why?
|
| Graft Rejection | 2 | 2010 | 4426 | 0.020 |
Why?
|
| Angiogenic Proteins | 1 | 2006 | 101 | 0.020 |
Why?
|
| Thermodynamics | 1 | 2007 | 599 | 0.020 |
Why?
|
| E2F Transcription Factors | 1 | 2006 | 269 | 0.020 |
Why?
|
| Sirolimus | 1 | 2012 | 1547 | 0.020 |
Why?
|
| Hypoxia-Inducible Factor 1 | 1 | 2006 | 193 | 0.020 |
Why?
|
| Nitric Oxide Synthase Type II | 1 | 2006 | 514 | 0.020 |
Why?
|
| Recombinant Proteins | 1 | 2014 | 6538 | 0.020 |
Why?
|
| Interleukin-12 | 1 | 2007 | 584 | 0.010 |
Why?
|
| Cell Hypoxia | 1 | 2007 | 658 | 0.010 |
Why?
|
| Female | 2 | 2021 | 391270 | 0.010 |
Why?
|
| Adenocarcinoma | 1 | 2021 | 6315 | 0.010 |
Why?
|
| Molecular Structure | 1 | 2007 | 1895 | 0.010 |
Why?
|
| Superoxide Dismutase | 1 | 2006 | 594 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 2008 | 58995 | 0.010 |
Why?
|
| Transcription Factors | 1 | 2022 | 12103 | 0.010 |
Why?
|
| Islets of Langerhans Transplantation | 1 | 2007 | 739 | 0.010 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2012 | 2873 | 0.010 |
Why?
|
| Blotting, Western | 1 | 2009 | 5039 | 0.010 |
Why?
|
| Swine | 1 | 2010 | 5899 | 0.010 |
Why?
|
| Pyridines | 1 | 2012 | 2879 | 0.010 |
Why?
|
| Cardiovascular Diseases | 1 | 2006 | 15757 | 0.010 |
Why?
|
| Transforming Growth Factor beta | 1 | 2007 | 1959 | 0.010 |
Why?
|
| Transplantation, Homologous | 1 | 2007 | 4810 | 0.010 |
Why?
|
| RNA Interference | 1 | 2007 | 2846 | 0.010 |
Why?
|
| Pulmonary Artery | 1 | 2006 | 1921 | 0.010 |
Why?
|
| Hemodynamics | 1 | 2006 | 4174 | 0.010 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2007 | 4357 | 0.010 |
Why?
|
| Aged | 1 | 2008 | 169152 | 0.010 |
Why?
|
| Oxygen | 1 | 2007 | 4193 | 0.010 |
Why?
|
| Kidney | 1 | 2010 | 7064 | 0.010 |
Why?
|
| Gene Expression Profiling | 1 | 2010 | 9411 | 0.010 |
Why?
|
| Mutation | 1 | 2016 | 29932 | 0.010 |
Why?
|
| Clinical Trials as Topic | 1 | 2006 | 8056 | 0.010 |
Why?
|